Information Letter on Aptivus 250 mg soft capsules: Missing or barely readable capsule imprint
2024.04.19
Active substance: tipranavir
The company Boehringer Ingelheim Pharma GmbH & Co. KG informs that batch 308715 of the medicinal product Aptivus 250 mg soft capsules (120 capsules per bottle) may contain capsules with only a faint imprint “TPV 250” or without this imprint at all. This is a purely optical error that only affects the appearance of the capsule. If you take other, similar-looking capsules in addition to Aptivus 250 mg, the company recommends taking Aptivus 250 mg as soon as possible after removing it from the bottle to avoid mix-up.